O	O	O	0	3	CD2	CD2	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	O	4	14	signalling	signalling	I-NP	NN	O	3	SUB	O
O	O	O	15	22	induces	induce	B-VP	VBZ	O	0	ROOT	O
O	O	O	23	38	phosphorylation	phosphorylation	B-NP	NN	O	3	OBJ	O
O	O	O	39	41	of	of	B-PP	IN	O	4	NMOD	O
T1	B-Protein	B-Protein	42	46	CREB	CREB	B-NP	NN	B-protein	5	PMOD	B-protein
O	O	O	47	49	in	in	B-PP	IN	O	4	NMOD	O
O	O	O	50	57	primary	primary	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	O	58	69	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	O	69	70	.	.	O	.	O	3	P	O

T17	B-Entity	B-Entity	72	80	Promoter	Promoter	B-NP	NN	B-DNA	2	NMOD	B-DNA
T17	I-Entity	I-Entity	81	90	sequences	sequence	I-NP	NNS	I-DNA	10	SUB	I-DNA
T17	I-Entity	I-Entity	91	101	responsive	responsive	B-ADJP	JJ	O	2	NMOD	O
T17	I-Entity	I-Entity	102	104	to	to	B-PP	TO	O	3	AMOD	O
T17,T18	I-Entity,B-Entity	I-Entity,B-Entity	105	111	cyclic	cyclic	B-NP	JJ	O	6	NMOD	O
T17,T18	I-Entity,I-Entity	I-Entity,I-Entity	112	115	AMP	AMP	I-NP	NN	O	4	PMOD	O
O	O	O	116	117	(	(	O	(	O	9	DEP	O
T19	B-Entity	B-Entity	117	121	cAMP	cAMP	B-NP	NN	O	9	DEP	O
O	O	O	121	122	)	)	O	)	O	6	NMOD	O
O	O	O	123	126	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	127	132	found	find	I-VP	VBN	O	10	VC	O
O	O	O	133	135	in	in	B-PP	IN	O	11	VMOD	O
O	O	O	136	137	a	a	B-NP	DT	O	14	NMOD	O
O	O	O	138	144	number	number	I-NP	NN	O	12	PMOD	O
O	O	O	145	147	of	of	B-PP	IN	O	14	NMOD	O
T20	B-Entity	B-Entity	148	156	cellular	cellular	B-NP	JJ	B-DNA	17	NMOD	B-DNA
T20	I-Entity	I-Entity	157	162	genes	gene	I-NP	NNS	I-DNA	15	PMOD	I-DNA
O	O	O	162	163	,	,	O	,	O	10	P	O
O	O	O	164	167	and	and	O	CC	O	10	VMOD	O
O	O	O	168	172	bind	bind	B-VP	VBP	O	10	VMOD	O
O	O	O	173	186	transcription	transcription	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	O	187	194	factors	factor	I-NP	NNS	I-protein	20	OBJ	I-protein
O	O	O	195	197	of	of	B-PP	IN	O	22	NMOD	O
O	O	O	198	201	the	the	B-NP	DT	O	29	NMOD	O
T21	B-Entity	B-Entity	202	206	cAMP	cAMP	I-NP	NN	B-protein	29	NMOD	B-protein
O	O	O	207	215	response	response	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	O	216	223	element	element	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	O	224	231	binding	binding	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	O	232	239	protein	protein	I-NP	NN	I-protein	23	PMOD	I-protein
O	O	O	240	241	(	(	O	(	O	32	DEP	O
O	O	O	241	245	CREB	CREB	B-NP	NN	B-protein	32	DEP	B-protein
O	O	O	245	246	)	)	O	)	O	29	NMOD	O
O	O	O	246	247	/	/	B-NP	SYM	O	29	NMOD	O
T2	B-Protein	B-Protein	247	257	activating	activate	B-VP	VBG	O	33	PMOD	O
T2	I-Protein	I-Protein	258	271	transcription	transcription	B-NP	NN	B-protein	36	NMOD	B-protein
T2	I-Protein	I-Protein	272	278	factor	factor	I-NP	NN	I-protein	38	NMOD	I-protein
T2	I-Protein	I-Protein	278	279	-	-	B-NP	HYPH	O	38	P	O
T2	I-Protein	I-Protein	279	280	1	1	I-NP	CD	O	44	NMOD	O
O	O	O	281	282	(	(	O	(	O	43	DEP	O
T3	B-Protein	B-Protein	282	285	ATF	ATF	B-NP	NN	B-protein	42	SUB	B-protein
T3	I-Protein	I-Protein	285	286	-	-	B-NP	HYPH	O	42	P	O
T3	I-Protein	I-Protein	286	287	1	1	I-NP	CD	O	43	DEP	O
O	O	O	287	288	)	)	O	)	O	38	NMOD	O
O	O	O	289	295	family	family	B-NP	NN	O	34	OBJ	O
O	O	O	295	296	.	.	O	.	O	10	P	O

O	O	O	297	299	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	300	304	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	305	309	used	use	I-VP	VBN	O	2	VC	O
O	O	O	310	311	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	312	317	human	human	I-NP	JJ	O	10	NMOD	O
O	O	O	318	319	T	T	I-NP	NN	O	10	NMOD	O
O	O	O	319	320	-	-	I-NP	HYPH	O	10	NMOD	O
O	O	O	320	332	lymphotropic	lymphotropic	I-NP	JJ	O	10	NMOD	O
O	O	O	333	338	virus	virus	I-NP	NN	O	10	NMOD	O
O	O	O	339	343	type	type	I-NP	NN	O	3	OBJ	O
O	O	O	344	345	1	1	I-NP	CD	O	10	NMOD	O
O	O	O	346	347	(	(	O	(	O	10	NMOD	O
O	O	O	347	351	HTLV	HTLV	O	NN	O	12	DEP	O
O	O	O	351	352	-	-	O	HYPH	O	15	P	O
O	O	O	352	353	1	1	O	CD	O	13	NMOD	O
O	O	O	353	354	)	)	O	)	O	15	DEP	O
O	O	O	355	360	model	model	B-NP	NN	O	15	DEP	O
O	O	O	361	363	of	of	B-PP	IN	O	17	NMOD	O
T22,T23	B-Entity,B-Entity	B-Entity,B-Entity	364	368	cAMP	cAMP	B-NP	NN	B-DNA	21	NMOD	B-DNA
T22	I-Entity	I-Entity	369	377	response	response	I-NP	NN	I-DNA	21	NMOD	I-DNA
T22	I-Entity	I-Entity	378	385	element	element	I-NP	NN	I-DNA	25	NMOD	I-DNA
O	O	O	386	387	(	(	O	(	O	24	DEP	O
T24	B-Entity	B-Entity	387	390	CRE	CRE	B-NP	NN	B-DNA	24	DEP	B-DNA
O	O	O	390	391	)	)	O	)	O	21	NMOD	O
O	O	O	392	405	transcription	transcription	B-NP	NN	O	18	PMOD	O
O	O	O	406	408	to	to	B-VP	TO	O	27	VMOD	O
O	O	O	409	420	investigate	investigate	I-VP	VB	O	17	NMOD	O
O	O	O	421	424	the	the	B-NP	DT	O	29	NMOD	O
O	O	O	425	434	influence	influence	I-NP	NN	O	27	OBJ	O
O	O	O	435	437	of	of	B-PP	IN	O	29	NMOD	O
O	O	O	438	448	lymphocyte	lymphocyte	B-NP	NN	O	32	NMOD	O
O	O	O	449	459	activation	activation	I-NP	NN	O	30	PMOD	O
O	O	O	460	462	on	on	B-PP	IN	O	29	NMOD	O
O	O	O	463	476	transcription	transcription	B-NP	NN	O	33	PMOD	O
O	O	O	477	481	from	from	B-PP	IN	O	34	NMOD	O
T25	B-Entity	B-Entity	482	492	homologous	homologous	B-NP	JJ	O	37	NMOD	O
T25	I-Entity	I-Entity	493	500	regions	region	I-NP	NNS	O	35	PMOD	O
T25	I-Entity	I-Entity	501	503	in	in	B-PP	IN	O	37	NMOD	O
T25	I-Entity	I-Entity	504	507	the	the	B-NP	DT	O	41	NMOD	O
T25	I-Entity	I-Entity	508	513	viral	viral	I-NP	JJ	B-DNA	41	NMOD	B-DNA
T25	I-Entity	I-Entity	514	522	promoter	promoter	I-NP	NN	I-DNA	38	PMOD	I-DNA
O	O	O	522	523	.	.	O	.	O	2	P	O

O	O	O	524	526	We	We	B-NP	PRP	O	3	SUB	O
O	O	O	527	537	previously	previously	B-ADVP	RB	O	3	VMOD	O
O	O	O	538	550	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	O	551	560	increased	increase	B-NP	VBN	O	8	NMOD	O
O	O	O	561	565	HTLV	HTLV	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	565	566	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	O	566	567	1	1	I-NP	CD	O	8	NMOD	O
O	O	O	568	581	transcription	transcription	I-NP	NN	O	3	OBJ	O
O	O	O	582	591	following	follow	B-PP	VBG	O	8	NMOD	O
T4	B-Protein	B-Protein	592	595	CD2	CD2	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	596	599	but	but	B-NP	CC	O	14	NMOD	O
O	O	O	600	603	not	not	I-NP	RB	O	11	DEP	O
O	O	O	604	607	CD3	CD3	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	608	616	receptor	receptor	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	O	617	622	cross	cross	O	AFX	O	3	VMOD	O
O	O	O	622	623	-	-	O	HYPH	O	15	P	O
O	O	O	623	630	linking	link	B-VP	VBG	O	15	DEP	O
O	O	O	630	631	.	.	O	.	O	3	P	O

O	O	O	632	634	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	635	647	hypothesized	hypothesize	B-VP	VBD	O	0	ROOT	O
O	O	O	648	652	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	653	657	this	this	B-NP	DT	O	7	NMOD	O
O	O	O	658	667	increased	increase	I-NP	VBN	O	7	NMOD	O
O	O	O	668	673	viral	viral	I-NP	JJ	O	7	NMOD	O
O	O	O	674	687	transcription	transcription	I-NP	NN	O	8	SUB	O
O	O	O	688	691	was	be	B-VP	VBD	O	3	SBAR	O
O	O	O	692	700	mediated	mediate	I-VP	VBN	O	8	VC	O
O	O	O	700	701	,	,	O	,	O	9	P	O
O	O	O	702	704	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	705	709	part	part	B-NP	NN	O	11	PMOD	O
O	O	O	709	710	,	,	O	,	O	9	P	O
O	O	O	711	718	through	through	B-PP	IN	O	9	VMOD	O
O	O	O	719	722	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	723	738	phosphorylation	phosphorylation	I-NP	NN	O	14	PMOD	O
O	O	O	739	741	of	of	B-PP	IN	O	16	NMOD	O
T5	B-Protein	B-Protein	742	746	CREB	CREB	B-NP	NN	B-protein	17	PMOD	B-protein
O	O	O	746	747	.	.	O	.	O	2	P	O

O	O	O	748	757	Therefore	Therefore	B-ADVP	RB	O	4	VMOD	O
O	O	O	757	758	,	,	O	,	O	4	P	O
O	O	O	759	761	we	we	B-NP	PRP	O	4	SUB	O
O	O	O	762	774	investigated	investigate	B-VP	VBD	O	0	ROOT	O
T6	B-Protein	B-Protein	775	778	CD2	CD2	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	779	782	and	and	I-NP	CC	O	8	NMOD	O
O	O	O	783	786	CD3	CD3	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	787	795	receptor	receptor	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	O	795	796	-	-	B-NP	HYPH	O	11	NMOD	O
O	O	O	796	804	mediated	mediate	I-NP	VBN	O	11	NMOD	O
O	O	O	805	815	signalling	signalling	I-NP	NN	O	4	OBJ	O
O	O	O	816	818	in	in	B-PP	IN	O	11	NMOD	O
O	O	O	819	826	primary	primary	B-NP	JJ	B-cell_type	18	NMOD	B-cell_type
O	O	O	827	832	human	human	I-NP	JJ	I-cell_type	18	NMOD	I-cell_type
O	O	O	833	843	peripheral	peripheral	I-NP	JJ	I-cell_type	18	NMOD	I-cell_type
O	O	O	844	849	blood	blood	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	O	850	861	mononuclear	mononuclear	I-NP	JJ	I-cell_type	18	NMOD	I-cell_type
O	O	O	862	867	cells	cell	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	O	868	869	(	(	O	(	O	21	DEP	O
O	O	O	869	873	PBMC	PBMC	B-NP	NN	B-cell_type	21	DEP	B-cell_type
O	O	O	873	874	)	)	O	)	O	18	NMOD	O
O	O	O	874	875	.	.	O	.	O	4	P	O

T7	B-Protein	B-Protein	876	879	CD2	CD2	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	879	880	,	,	O	,	O	5	P	O
O	O	O	881	884	but	but	O	CC	O	5	NMOD	O
O	O	O	885	888	not	not	O	RB	O	3	DEP	O
T26	B-Entity	B-Entity	889	892	CD3	CD3	B-NP	NN	B-protein	0	ROOT	B-protein
O	O	O	892	893	,	,	O	,	O	5	P	O
O	O	O	894	899	cross	cross	O	AFX	O	5	P	O
O	O	O	899	900	-	-	O	HYPH	O	7	P	O
O	O	O	900	907	linking	link	B-VP	VBG	O	5	NMOD	O
O	O	O	908	917	increased	increase	B-NP	VBN	O	11	NMOD	O
T27	B-Entity	B-Entity	918	922	cAMP	cAMP	I-NP	NN	O	9	OBJ	O
O	O	O	923	931	detected	detect	B-VP	VBN	O	11	NMOD	O
O	O	O	932	934	by	by	B-PP	IN	O	12	VMOD	O
O	O	O	935	946	competitive	competitive	B-NP	JJ	B-protein	15	NMOD	B-protein
O	O	O	947	953	enzyme	enzyme	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	O	953	954	-	-	B-VP	HYPH	O	15	NMOD	O
O	O	O	954	960	linked	link	B-NP	VBN	O	19	NMOD	O
O	O	O	961	974	immunosorbent	immunosorbent	I-NP	NN	O	19	NMOD	O
O	O	O	975	980	assay	assay	I-NP	NN	O	16	PMOD	O
O	O	O	981	982	(	(	O	(	O	22	DEP	O
O	O	O	982	987	ELISA	ELISA	B-NP	NN	O	22	DEP	O
O	O	O	987	988	)	)	O	)	O	19	NMOD	O
O	O	O	989	1002	approximately	approximately	B-ADVP	RB	O	19	NMOD	O
O	O	O	1003	1011	fourfold	fourfold	I-ADVP	RB	O	23	AMOD	O
O	O	O	1011	1012	.	.	O	.	O	5	P	O

T8	B-Protein	B-Protein	1013	1016	CD2	CD2	B-NP	NN	B-protein	0	ROOT	B-protein
O	O	O	1017	1022	cross	cross	O	AFX	O	1	NMOD	O
O	O	O	1022	1023	-	-	B-VP	HYPH	O	2	VMOD	O
O	O	O	1023	1030	linking	link	I-VP	VBG	O	3	VC	O
O	O	O	1031	1043	concurrently	concurrently	B-NP	RB	O	6	AMOD	O
O	O	O	1044	1053	increased	increase	I-NP	VBN	O	7	NMOD	O
O	O	O	1054	1069	phosphorylation	phosphorylation	I-NP	NN	O	4	OBJ	O
O	O	O	1070	1072	of	of	B-PP	IN	O	7	NMOD	O
T9	B-Protein	B-Protein	1073	1077	CREB	CREB	B-NP	NN	B-protein	8	PMOD	B-protein
O	O	O	1078	1086	detected	detect	B-VP	VBN	O	9	NMOD	O
O	O	O	1087	1089	by	by	B-PP	IN	O	10	VMOD	O
O	O	O	1090	1100	immunoblot	immunoblot	B-NP	NN	O	13	NMOD	O
O	O	O	1101	1106	assay	assay	I-NP	NN	O	11	PMOD	O
O	O	O	1107	1116	eightfold	eightfold	B-ADVP	RB	O	13	NMOD	O
O	O	O	1116	1117	.	.	O	.	O	1	P	O

O	O	O	1118	1128	Consistent	Consistent	B-ADJP	JJ	O	16	VMOD	O
O	O	O	1129	1133	with	with	B-PP	IN	O	1	AMOD	O
O	O	O	1134	1138	post	post	B-NP	AFX	O	6	NMOD	O
O	O	O	1138	1139	-	-	I-NP	HYPH	O	6	NMOD	O
O	O	O	1139	1152	translational	translational	I-NP	JJ	O	6	NMOD	O
O	O	O	1153	1163	regulation	regulation	I-NP	NN	O	2	PMOD	O
O	O	O	1163	1164	,	,	O	,	O	16	P	O
O	O	O	1165	1167	no	no	B-NP	DT	O	9	NMOD	O
O	O	O	1168	1174	change	change	I-NP	NN	O	16	SUB	O
O	O	O	1175	1177	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	1178	1183	total	total	B-NP	JJ	O	12	NMOD	O
O	O	O	1184	1189	level	level	I-NP	NN	O	10	PMOD	O
O	O	O	1190	1192	of	of	B-PP	IN	O	12	NMOD	O
T10	B-Protein	B-Protein	1193	1197	CREB	CREB	B-NP	NN	B-protein	15	NMOD	B-protein
O	O	O	1198	1205	protein	protein	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	O	1206	1209	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1210	1218	observed	observe	I-VP	VBN	O	16	VC	O
O	O	O	1218	1219	.	.	O	.	O	16	P	O

O	O	O	1220	1235	Phosphorylation	Phosphorylation	B-NP	NN	O	4	SUB	O
O	O	O	1236	1238	of	of	B-PP	IN	O	1	NMOD	O
T11	B-Protein	B-Protein	1239	1243	CREB	CREB	B-NP	NN	B-protein	2	PMOD	B-protein
O	O	O	1244	1252	occurred	occur	B-VP	VBD	O	0	ROOT	O
O	O	O	1253	1260	through	through	B-PP	IN	O	4	VMOD	O
O	O	O	1261	1262	a	a	B-NP	DT	O	8	NMOD	O
O	O	O	1263	1273	herbimycin	herbimycin	I-NP	NN	O	8	NMOD	O
O	O	O	1274	1275	A	A	I-NP	NN	O	12	NMOD	O
O	O	O	1276	1279	and	and	I-NP	CC	O	12	NMOD	O
T28	B-Entity	B-Entity	1280	1282	Rp	Rp	I-NP	NN	B-protein	12	NMOD	B-protein
T28	I-Entity	I-Entity	1282	1283	-	-	B-NP	HYPH	O	12	P	O
T28	I-Entity	I-Entity	1283	1287	cAMP	cAMP	I-NP	NN	O	15	NMOD	O
O	O	O	1287	1288	-	-	B-NP	HYPH	O	15	NMOD	O
O	O	O	1289	1298	sensitive	sensitive	I-NP	JJ	O	15	NMOD	O
O	O	O	1299	1306	pathway	pathway	I-NP	NN	O	5	PMOD	O
O	O	O	1306	1307	,	,	O	,	O	4	P	O
O	O	O	1308	1318	suggesting	suggest	B-VP	VBG	O	4	VMOD	O
O	O	O	1319	1334	phosphorylation	phosphorylation	B-NP	NN	O	17	OBJ	O
O	O	O	1335	1343	required	require	B-VP	VBD	O	18	NMOD	O
O	O	O	1344	1354	antecedent	antecedent	B-NP	JJ	O	21	NMOD	O
O	O	O	1355	1365	activation	activation	I-NP	NN	O	19	OBJ	O
O	O	O	1366	1368	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	1369	1373	both	both	O	CC	O	26	NMOD	O
O	O	O	1374	1381	protein	protein	B-NP	NN	B-protein	26	NMOD	B-protein
T29	B-Entity	B-Entity	1382	1390	tyrosine	tyrosine	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	O	1391	1398	kinases	kinase	I-NP	NNS	I-protein	33	NMOD	I-protein
O	O	O	1399	1400	(	(	O	(	O	29	DEP	O
O	O	O	1400	1403	PTK	PTK	B-NP	NN	B-protein	29	DEP	B-protein
O	O	O	1403	1404	)	)	O	)	O	26	NMOD	O
O	O	O	1405	1408	and	and	O	CC	O	33	NMOD	O
T30	B-Entity	B-Entity	1409	1416	protein	protein	B-NP	NN	B-protein	33	NMOD	B-protein
T30	I-Entity	I-Entity	1417	1423	kinase	kinase	I-NP	NN	I-protein	33	NMOD	I-protein
T30	I-Entity	I-Entity	1424	1425	A	A	I-NP	NN	I-protein	22	PMOD	I-protein
O	O	O	1426	1427	(	(	O	(	O	36	DEP	O
T31	B-Entity	B-Entity	1427	1430	PKA	PKA	B-NP	NN	B-protein	36	DEP	B-protein
O	O	O	1430	1431	)	)	O	)	O	33	NMOD	O
O	O	O	1431	1432	.	.	O	.	O	4	P	O

O	O	O	1433	1437	Both	Both	O	CC	O	4	NMOD	O
T12	B-Protein	B-Protein	1438	1441	CD2	CD2	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	1442	1445	and	and	I-NP	CC	O	4	NMOD	O
T32	B-Entity	B-Entity	1446	1449	CD3	CD3	I-NP	NN	B-protein	0	ROOT	B-protein
O	O	O	1450	1455	cross	cross	O	AFX	O	4	NMOD	O
O	O	O	1455	1456	-	-	O	HYPH	O	5	P	O
O	O	O	1456	1463	linking	link	B-VP	VBG	O	5	VMOD	O
O	O	O	1464	1473	increased	increase	B-NP	VBN	O	9	NMOD	O
O	O	O	1474	1481	binding	binding	I-NP	NN	O	7	OBJ	O
O	O	O	1482	1484	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	1485	1492	nuclear	nuclear	B-NP	JJ	B-protein	12	NMOD	B-protein
O	O	O	1493	1501	proteins	protein	I-NP	NNS	I-protein	10	PMOD	I-protein
O	O	O	1502	1504	to	to	B-PP	TO	O	9	NMOD	O
O	O	O	1505	1506	a	a	B-NP	DT	O	18	NMOD	O
O	O	O	1507	1520	radiolabelled	radiolabelle	I-NP	VBN	O	18	NMOD	O
T33	B-Entity	B-Entity	1521	1524	CRE	CRE	I-NP	NN	O	18	NMOD	O
T33	I-Entity	I-Entity	1525	1540	oligonucleotide	oligonucleotide	I-NP	NN	O	18	NMOD	O
T33	I-Entity	I-Entity	1541	1546	probe	probe	I-NP	NN	O	13	PMOD	O
O	O	O	1547	1549	in	in	B-PP	IN	O	7	VMOD	O
O	O	O	1550	1565	electrophoretic	electrophoretic	B-NP	JJ	O	23	NMOD	O
O	O	O	1566	1574	mobility	mobility	I-NP	NN	O	23	NMOD	O
O	O	O	1575	1580	shift	shift	I-NP	NN	O	23	NMOD	O
O	O	O	1581	1587	assays	assay	I-NP	NNS	O	19	PMOD	O
O	O	O	1588	1598	suggesting	suggest	B-VP	VBG	O	7	VMOD	O
O	O	O	1599	1603	that	that	B-SBAR	IN	O	24	VMOD	O
O	O	O	1604	1614	lymphocyte	lymphocyte	B-NP	NN	O	27	NMOD	O
O	O	O	1615	1625	activation	activation	I-NP	NN	O	28	SUB	O
O	O	O	1626	1634	enhances	enhance	B-VP	VBZ	O	25	SBAR	O
O	O	O	1635	1642	binding	binding	B-NP	NN	O	28	OBJ	O
O	O	O	1643	1656	independently	independently	B-ADVP	RB	O	28	VMOD	O
O	O	O	1657	1659	of	of	B-PP	IN	O	30	AMOD	O
O	O	O	1660	1675	phosphorylation	phosphorylation	B-NP	NN	O	31	PMOD	O
O	O	O	1676	1678	of	of	B-PP	IN	O	32	NMOD	O
T13	B-Protein	B-Protein	1679	1683	CREB	CREB	B-NP	NN	B-protein	33	PMOD	B-protein
O	O	O	1684	1686	at	at	B-PP	IN	O	32	NMOD	O
T34	B-Entity	B-Entity	1687	1693	serine	serine	B-NP	NN	O	35	PMOD	O
T34	I-Entity	I-Entity	1694	1697	133	133	I-NP	CD	O	36	NMOD	O
O	O	O	1697	1698	.	.	O	.	O	4	P	O

O	O	O	1699	1704	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1705	1709	data	datum	I-NP	NNS	O	3	SUB	O
O	O	O	1710	1718	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	1719	1727	specific	specific	B-NP	JJ	O	5	NMOD	O
O	O	O	1728	1738	modulation	modulation	I-NP	NN	O	3	OBJ	O
O	O	O	1739	1741	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	1742	1745	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	1746	1750	CREB	CREB	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	1750	1751	/	/	B-NP	SYM	O	10	NMOD	O
T14	B-Protein	B-Protein	1751	1754	ATF	ATF	I-NP	NN	B-protein	13	NMOD	B-protein
T14	I-Protein	I-Protein	1754	1755	-	-	B-NP	HYPH	O	13	P	O
T14	I-Protein	I-Protein	1755	1756	1	1	I-NP	CD	O	13	NMOD	O
O	O	O	1757	1763	family	family	I-NP	NN	O	6	PMOD	O
O	O	O	1764	1766	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	1767	1780	transcription	transcription	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	1781	1788	factors	factor	I-NP	NNS	I-protein	14	PMOD	I-protein
O	O	O	1789	1791	by	by	B-PP	IN	O	5	NMOD	O
O	O	O	1792	1795	the	the	B-NP	DT	O	21	NMOD	O
T15	B-Protein	B-Protein	1796	1799	CD2	CD2	I-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	1800	1810	signalling	signalling	I-NP	NN	O	21	NMOD	O
O	O	O	1811	1818	pathway	pathway	I-NP	NN	O	17	PMOD	O
O	O	O	1819	1822	and	and	O	CC	O	3	VMOD	O
O	O	O	1823	1830	suggest	suggest	B-VP	VBP	O	3	VMOD	O
T16	B-Protein	B-Protein	1831	1834	CD2	CD2	B-NP	NN	B-protein	26	NMOD	B-protein
T16	I-Protein	I-Protein	1835	1843	receptor	receptor	I-NP	NN	O	26	NMOD	O
O	O	O	1844	1854	modulation	modulation	I-NP	NN	O	23	OBJ	O
O	O	O	1855	1857	of	of	B-PP	IN	O	26	NMOD	O
T35	B-Entity	B-Entity	1858	1861	CRE	CRE	B-NP	NN	B-DNA	31	NMOD	B-DNA
O	O	O	1861	1862	-	-	B-NP	HYPH	O	31	P	O
O	O	O	1862	1870	mediated	mediate	I-NP	VBN	O	31	NMOD	O
O	O	O	1871	1884	transcription	transcription	I-NP	NN	O	27	PMOD	O
O	O	O	1885	1894	following	follow	B-PP	VBG	O	31	NMOD	O
T36	B-Entity	B-Entity	1895	1901	ligand	ligand	B-NP	NN	O	34	NMOD	O
O	O	O	1902	1912	engagement	engagement	I-NP	NN	O	32	PMOD	O
O	O	O	1913	1914	(	(	O	(	O	46	DEP	O
O	O	O	1914	1915	e	e	B-NP	NN	O	38	NMOD	O
O	O	O	1915	1916	.	.	O	.	O	36	P	O
O	O	O	1916	1917	g	g	B-NP	NN	O	40	NMOD	O
O	O	O	1917	1918	.	.	B-NP	.	O	38	P	O
O	O	O	1919	1923	cell	cell	I-NP	NN	O	46	DEP	O
O	O	O	1923	1924	-	-	B-ADJP	HYPH	O	40	P	O
O	O	O	1924	1926	to	to	B-PP	TO	O	40	NMOD	O
O	O	O	1926	1927	-	-	B-NP	HYPH	O	45	NMOD	O
O	O	O	1927	1931	cell	cell	I-NP	NN	O	45	NMOD	O
O	O	O	1932	1939	contact	contact	I-NP	NN	O	42	PMOD	O
O	O	O	1939	1940	)	)	O	)	O	34	NMOD	O
O	O	O	1940	1941	.	.	O	.	O	3	P	O
